Home > Journals > Minerva Anestesiologica > Past Issues > Articles online first > Minerva Anestesiologica 2022 Jul 05

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Review Article   

Minerva Anestesiologica 2022 Jul 05

DOI: 10.23736/S0375-9393.22.16654-X

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Norepinephrine versus phenylephrine for post-spinal hypotension in parturients undergoing caesarean section: a systematic review and meta-analysis

Kamlesh KUMARI 1, Kriti CHAUDHARY 2, Priyanka SETHI 1, Darshana RATHOD 1, Tanvi MESHRAM 1, Nikhil KOTHARI 1, Ankur SHARMA 1, Pradeep BHATIA 1, Surjit SINGH 1

1 Department of Anaesthesiology and Critical care, All India Institute of Medical Sciences, Jodhpur, India; 2 Department of Anaesthesiology, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India


PDF


INTRODUCTION: Multiple studies have compared varying prophylactic and therapeutic doses of norepinephrine and phenylephrine given as either intermittent bolus or fixed-rate infusion to combat post-spinal hypotension in patients undergoing cesarean section (CS). We conducted a systematic review to figure out the best alternative to treat post-spinal hypotension.
EVIDENCE ACQUISITION: PubMed and Cochrane databases were extensively searched for eligible RCTs. A total of 15 studies were found eligible and analysed for the incidence of maternal bradycardia as the primary outcome and other maternal adverse effects, fetal acidosis and Apgar scores at 1 and 5 min as the secondary outcome. Data was analysed using Review Manager Version 5.3. software.
EVIDENCE SYNTHESIS: There was no significant difference in the efficacy of norepinephrine and phenylephrine for managing post-spinal hypotension [OR = 1.15 (95% CI=0.91-1.45),P=0.24, I2=0%,moderate quality] in parturients undergoing CS. Odds of incidence of maternal bradycardia decrease significantly by 61% with norepinephrine versus phenylephrine [OR = 0.39 (95% CI = 0.31-0.49),P<0.00001, I2=27%,high quality evidence]. Significant higher umbilical artery mean pH values were observed with NE versus PE [MD = 0.0 (95%CI=0.00 to 0.01),P=0.03], although not clinical relevant. However, no significant difference was found in the incidence of other maternal adverse effects and fetal outcomes.
CONCLUSIONS: Comparable efficacy for management of post-spinal hypotension, though, norepinephrine was found to cause less incidence of maternal bradycardia as compared to phenylephrine.


KEY WORDS: Anesthesia; Cesarean section; Hypotension; Norepinephrine; Phenylephrine; Spinal

top of page